Discover how much money can be saved in your clinical trial!

Screen Shot 2020 10 07 at 10.36.19 AM

Prevent Professional Research Subjects With The VCT Global Research Subject Database: European Snapshot

A quick look at some screening data in 3 close European countries demonstrates how research subjects travel to screen concurrently at multiple different sites. Professional research subjects often travel large distances between states or countries to do so. Some travel is within the same country to different sites, but there is significant travel between countries. …

Read more

Screen Shot 2020 06 24 at 9.32.25 PM

Prevent Professional Research Subjects With Verified Clinical Trials

Professional research subjects cause issues with placebo rates, data quality and safety.  The issue is more common than most would think.  Upwards of 10% of research subjects will attempt to enroll in more than one clinical trial concurrently or before a safe and mandatory wash out period has occurred. Without a tool like Verified Clinical …

Read more

Verified Video

Verified Clinical Trials Offers Virtual Clinical Trial Solution To Prevent Co-Enrollment or Duplicate Subjects

Conducting virtual or remote clinical trials? Verify your research subjects eligibility and ensure they are not concurrently enrolling in multiple clinical trials at once. Avoid co-enrollment in clinical trials or duplicate subjects in clinical trials as well as protocol violations. Select better quality subjects for your trial so that you can meet her in points …

Read more

Screen Shot 2019 03 31 at 10.25.15 PM

Duplicate Or Professional Research Subjects Result In Failed Clinical Trials

Duplicate or professional research subjects can be the silent killer of your clinical trial. The issue exists in all phases of clinical trials research, across the globe and across most therapeutic areas. As the data grows, we realize how important it is to use the Verified Clinical Trials (VCT) research subject registry to prevent these …

Read more

Sees Progress in the Understanding

Verified Clinical Trials Sees Progress In The Understanding and Acceptance of Duplicate Subjects In Clinical Trials

We have seen tremendous progress within the clinical trials research industry in understanding the scope of the issue with duplicate subjects in clinical trials  or professional research subjects over the past few years.  Verified Clinical Trials (VCT) provides an easy to implement cost-savings approach to prevent duplicate subjects and other important protocol violations in your …

Read more

Screen Shot 2018 08 11 at 12.17.32 PM

Subject Registries Reduce Duplicate Subjects Entering CNS Studies

Verified Clinical Trials (VCT) is the global research subject database registry utilized across all phases of clinical trials research to prevent duplicate subjects and other key protocol violations. Data shows that a research subject registry will detect and prevent duplicate subjects and other protocol violations.  Up to 10% in CNS clinical trials and much higher …

Read more

Key Research Sites In Germany Join Verified Clinical Trials Research Subject Registry To Prevent Duplicate Subjects & Over Enrollment To Improve Safety & Data Quality

Several premier research centers in Germany have led the initiative and joined the global Verified Clinical Trials (VCT) research subject database registry to prevent duplicate subjects and other important protocol violations in an effort to improve safety and data quality in their clinical trials. Key research sites in Germany join Verified Clinical Trials to prevent …

Read more

Screen Shot 2019 05 30 at 12.33.36 PM

Understanding Research Subjects Behaviors & Travel Habits: Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …

Read more